- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Apr 25, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,612 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
AVLL3 | R$3.50 | -7.7% | 26.4% | R$683.7m | R$9.90 | PS1.4x | E101.9% | n/a | Consumer Durables | ||
ALKT | US$23.86 | -0.7% | 98.8% | US$2.3b | US$28.70 | PS8.8x | E80.1% | n/a | Software | ||
TGTX | US$13.91 | -0.6% | -40.4% | US$2.0b | US$29.75 | PE159.1x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$23.16 | 5.7% | 29.5% | US$2.5b | US$25.50 | PE24.1x | E43.0% | 3.6% | Energy | ||
ZVRA | US$4.52 | 0.4% | -13.2% | US$189.2m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
ESTA | US$48.54 | -7.7% | -29.1% | US$1.3b | US$59.29 | PS8.1x | E65.4% | n/a | Healthcare | ||
PRL | CA$22.37 | 0.6% | 241.0% | CA$767.9m | CA$24.37 | PE20.2x | E33.6% | 2.1% | Diversified Financials | ||
AXSM | US$71.52 | 8.8% | 0.5% | US$3.4b | US$121.13 | PS12.5x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$176.03 | 5.1% | 89.6% | US$9.8b | US$206.21 | PE75.5x | E27.2% | n/a | Household | ||
RCEL | US$8.30 | -6.4% | -45.3% | US$214.1m | US$26.43 | PS4.3x | E61.1% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.23 | -10.8% | 154.8% | US$483.2m | US$11.60 | PS48.4x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$23.16 | 4.0% | 47.5% | R$4.0b | R$28.75 | PE12.1x | E25.1% | 2.0% | Consumer Durables | ||
NVDA | US$826.32 | -2.4% | 203.5% | US$2.0t | US$995.62 | PE68.3x | E22.9% | 0.02% | Semiconductors | ||
GTHX | US$3.86 | -7.4% | 43.0% | US$201.5m | US$8.50 | PS2.4x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$143.71 | -1.0% | -26.7% | US$18.2b | US$220.00 | PS9.9x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ASND | US$136.93 | -2.8% | 77.9% | US$7.8b | US$177.45 | PS27.3x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
EH | US$18.19 | -0.5% | 69.2% | US$1.2b | US$23.83 | PS71x | E97.6% | n/a | Capital Goods | ||
LKNC.Y | US$21.05 | -2.8% | -18.3% | US$5.9b | n/a | PE15x | E24.4% | n/a | Consumer Services | ||
A211050 | ₩4,900.00 | 0% | 120.1% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
MVW | kr8.20 | -2.4% | 7.0% | kr268.3m | kr13.00 | PS24.4x | E66.8% | n/a | Materials | ||
533286 | ₹417.95 | 27.2% | 166.8% | ₹85.0b | ₹345.00 | PE30x | E40.9% | 1.0% | Materials | ||
ELABS | kr16.66 | 14.1% | 42.2% | kr1.7b | kr25.00 | PS25.6x | E124.6% | n/a | Software | ||
FWRY | ج.م6.10 | -14.1% | 2.3% | ج.م20.8b | ج.م7.20 | PE33.6x | E34.8% | n/a | Diversified Financials |